[1] Clavé A, Fazilleau F, Dumser D, et al. Efficacy of tranexamic acid on blood loss after primaryCementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control Study in 70 patients. Orthop Traumatol Surg Res. 2012;98:484-490.
[2] Ronsencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion hemoglobin European Overview(OSTHEO) study:blood management in elective knee and hip arth roplasty in Europe. Transfusion. 2003;43: 459-469.
[3] Lee YC, Park SJ, Kim JS, et al. Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. J Clin Anesth. 2013;25:393-398.
[4] Borghi B, Borghi R. Blood-saving techniques. Transplant Proc. 2011;43:333-337.
[5] Huang F, Wu D, Ma G, et al. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014;186(1):318-327.
[6] Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am.1999;81(1):2.
[7] Wei W, Wei B. Comparison of Topical and Intravenous Tranexamic Acid on Blood Loss and Transfusion Rates in Total Hip Arthroplasty. J Arthroplasty. 2014.
[8] Engoren M, Mitchell E, Perring P, et al. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture. J Trauma. 2008;65(6):1411-1415.
[9] Bochicchio GV, Napolitano L, Joshi M, et al. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg. 2008;32(10): 2185-2189.
[10] Weber EW, Slappendel R, Prins MH, et al. Perioperative blood transfusion and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg.2005;100(5):1416-1421.
[11] Hawi N, Kendoff DO, Hessling U, et al. Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty. Int Orthop. 2014;38(8):1603.
[12] Horstmann WG, Swierstra MJ, Ohanis D, et al. Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. Int Orthop. 2014;38(1):13.
[13] Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50(4):753.
[14] Alshryda S, Mason J, Sarda P, et al. Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Hip Replacement A Randomized Controlled Trial (TRANX-H). J Bone Joint Surg Am. 2013;95:1969.
[15] Wind TC, Barfield WR, Moskal JT. The Effect of Tranexamic Acid on Transfusion Rate in Primary Total Hip Arthroplasty. J Arthroplasty. 2014;29(2):387-389.
[16] Martin JG, Cassatt KB, Kincaid-Cinnamon KA, et al. Topical Administration of Tranexamic Acid in Primary Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2013.
[17] Konig G, Hamlin BR, Waters JH. Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates in Total Hip and Total Knee Arthroplasty. J Arthroplasty. 2013;28:1473.
[18] Fiechtner BK,Nuttall GA,Johnson ME,et al.Plasma tranexamic acid concentrations during cardiopulmonary bypassv.Anesth Analg. 2001;92(5):1131-1136.
[19] Hynes MC,Calder P,Rosenfeld P,et al. The use of tranexamic acid to reduce blood loss during total hip arthroplasty:an observational study. Ann R Coil Surg Engl. 2005;87(2): 99-101.
[20] Fiechtner BK,Nuttall GA,Johnson ME,et al.Plasma tranexamic acid concentrations during cardiopulmonary bypassv.Anesth Analg. 2001;92(5):1131-1136.
[21] Singh J, Ballal MS, Mitchell P, et al.Effects of tranexamie acid on bloodloss during THA. J Orthop Surg. 2010;18(3):282-286.
[22] Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for Minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;3:CD001886.
[23] Royston D. Blood-sparing drugs:aprotinin,tranexamic acid,andepsilon-aminocaproic acid. Int Anesthesiol Clin. 1995;33(1):155-179.
[24] Alshryda S,Sarda P,Sukeik M,et al.Tranexamic acid in total knee replacement:a systematic review and meta-analysis. J Bone Joint Surg Br. 2011;93(12):1577-1585.
[25] Leveille GA, Pardini RS, Tillotson JA. Influence of medium-chain triglycerides on lipid metabolism in the chick. Lipids. 1967;2(6): 461-466.
[26] Hynes MC, Calder P, Rosenfeld P, et al.The use oftYaneKamlc acid to reduce blood 10ss during total hip arthmplasty!an observational study. Ann R Coll Surg Engl. 2005;87(2):99-101.
[27] Benoni G, Fredin H, Knebel R, et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand. 2001;72:442.
[28] Husted H, Blønd L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand. 2003;74:665.
[29] Lemay E, Guay J, Côté C, et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth. 2004;51: 31.
[30] Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 2005;76:314.
[31] Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg. 2000;120:518.
[32] Molloy DO,Archbold HA,Ogonda L,et al.Comparison of topical Fibrin spray and tranexamic acid on blood loss after total knee replacement:a prospective,randomised controlled trial.J Bone Joint Surg Br. 2007;89(3):306-309.
[33] Hynes M,Calder P,Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee. 2003; 10(4):375-377.
[34] Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty. 2014;29(2):387.
[35] Kim YH, Cho SH, Kim RS. Drainage versus nondrainage in simultaneous bilateral total hip arthroplasties. J Anhroplaty. 1998;13(2):156-161.
[36] Southern EP,Huo MH,Mehta JR,et al. Unwashed wound drainage blood. What are wegiving ourpatients. Clin Orthop. 1995;320:235-246.
[37] Lozano M,Basora M,Peidro L,et al.Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang. 2008;95(1):39-44.
[38] Lerler BK.Ultrasonngraphy and diagnosis of venous thromboem bolism. Circulation. 2004;109(12 Supp1):19-24.
[39] Barnes CL, Nelson CL, Nix ML, et al. Duplex scanning versus venography as a screening examination in total hip arthroplasty patients. Clin Orthop Relat Res. 1991;(271):180.
[40] Grady-Benson JC, Oishi CS, Hanson PB, et al. Routine postoperative duplex ultrosonography screening and monitoring for the detection of deep vein thrombosis. Clin Orthop Relat Res. 1994;307:130.
[41] Tremaine DM, Choroszy CJ, Menking SA. Deep vein thrombosis in the total hip arthroplasty patient after hospital discharge. J Vase Tech. 1992;16:23.
[42] Sukeik M, Alshryda S,Haddad FS,et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011;93(1):39-46. |